Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 outpatients meta-analysis

CoV-Early (Gharbharan)
  NCT04589949		 RCTconvalescent plasma treatmentplaceboCOVID 19 outpatientslow
207/209 inconclusive
    CoV-Early (Gharbharan)
          NCT04589949    		 RCTEarly convalescent plasma.placeboCOVID 19 outpatientslow
    		207/209 inconclusive
      CONV-ERT
              NCT04621123      		 RCTconvalescent plasma treatmentplaceboCOVID 19 outpatientslow
      		188/160 inconclusive
        C3PO
                  NCT04355767        		 RCTconvalescent plasma treatmentplaceboCOVID 19 outpatientssome concern
        		257/254 inconclusive
        • inconclusive 9 % decrease in hospitalization or death (PE) with a moderate degree of certainty due to some concern in risk of bias

        PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
        Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).

         

        - About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons